KAMAL HAMED - Chief Medical Officer at Spero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
SPRO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by KAMAL HAMED since 08 Feb 2025

Holdings reported by KAMAL HAMED for Spero Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 788,117 $1,079,720 $1.37 02 Feb 2024 Direct

Transactions reported by KAMAL HAMED for Spero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.